Advaxis, Inc. announced the appointment of Daniel J. O'Connor to the position of Senior Vice President, Chief Legal and Business Development Officer. Mr. O'Connor, age 48, has fifteen years of executive, legal, and regulatory experience in the biopharmaceutical industry with ImClone Systems, PharmaNet and Bracco Diagnostics.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.21 USD | 0.00% |
|
+7.97% | -68.52% |
![Consensus](/images/consensus_flch.gif)
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-68.52% | 10.35M | |
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |
- Stock Market
- Equities
- ADXS Stock
- News Ayala Pharmaceuticals, Inc.
- Advaxis Appoints Daniel J. O'Connor to Senior Vice President, Chief Legal and Business Development Officer